See below for details of all PrecisionLife news, events and media activity as well as links to Disease Studies, research, and publications.
Anyone for tea? Why Alzheimer’s drug discovery might be targeting the impossible
Unique approach to precision medicine could reverse the trend in Alzheimer’s disease drug discovery and development Clinical trials in…
27/09/21
BIA Bioscience Forum
London, 14 October 2021 PrecisionLife CEO, Dr Steve Gardner, will join an expert panel to discuss access to NHS…
24/09/21
Neuropsychiatric Drug Development Summit
Online, 29-30 September 2021 Members of the PrecisionLife team will join leaders from the likes of Sunovion, Merck, Takeda,…
24/09/21
Best Chronic Disease Biology Company 2021 awarded to PrecisionLife
OXFORD, UK The International Life Sciences Awards has named PrecisionLife as the Best Chronic Disease Biology R&D Company 2021.
20/09/21
Complexity of disease biology gives opportunities for drug discovery
Late-stage clinical trials incur the biggest costs of bringing new drugs to market. Increasingly clinical trial failures happen late….
1/09/21
Understanding AI and its important role in MND research
“The search for new drugs to help people living with MND is long and challenging, but it is one…
22/07/21
Precision medicine and chronic disease
Chronic diseases, which account for 85% of healthcare costs, still have significant remaining pockets of unmet medical need that…
15/07/21
Combinatorial Analysis of Phenotypic and Clinical Risk Factors Associated With Hospitalized COVID-19 Patients
The study undertaken by PrecisionLife and Optum Labs leaders Taryn O. Hall and Kathy T.H. Zheng using data from…
8/07/21
From Pepsi to PrecisionLife
A Q&A with our Executive Chairman Ray Pawlicki reflecting on a senior leadership career that moved from Pepsico, to…
24/06/21Ray Pawlicki, Previously CIO at Biogen and Novartis, Joins PrecisionLife as Executive Chair to Accelerate Strategic Expansion
OXFORD, UK June 24th, 2021 –
24/06/21
Combinatorial Approaches to Managing Ancestry Effects in Chronic Disease Genetics
by Jason Sardell, Ph.D. Statistical/Population Geneticist
7/06/21
Combinatorial analytics: An essential tool for the delivery of precision medicine and precision agriculture
An Opinion, published in the new Open Access Journal Artificial Intelligence in the Life Sciences from Elsevier, describes the…
31/05/21
PrecisionLife and Cyclica sign strategic partnership combining leading data-driven biology and chemistry platforms to create a rapid innovation engine for drug discovery
OXFORD and TORONTO, May 17th, 2021
17/05/21
Bio Digital 2021
10-11 June 2021 Accelerating a BIO-Revolution through global partnerships, collaboration, and thought leadership We are joining the the world’s…
28/04/21
BioNJ’s 11th Annual BioPartnering Conference
Tuesday, May 18 & Wednesday, May 19, 2021 To discuss our extensive pipeline of drug discovery programs that covery…
28/04/21
Genomics & Precision Medicine, April 27th – PMLS Virtual Series 2021
Among the best investments ever made in a technology has been the ability to sequence, annotate, and make functional…
15/04/21
PrecisionLife unveils new spin-out Synomics taking its proven analytics platform into animal and crop health sectors
OXFORD, UK, April 7, 2021 PrecisionLife Ltd, leaders in combinatorial analytics, today unveils the launch of its new spin-out…
7/04/21
Living up to Company Values – Trust – The Importance of Information Security
PrecisionLife recognizes the privilege and responsibility inherent in working with patient and customer datasets and is wholly committed to…
6/04/21